LYON, France — The first oral small molecule anti–proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor appears to be effective in not only lowering low-density lipoprotein...
BASEL, SWITZERLAND — The anti-inflammatory agent colchicine failed to show significant benefit in the treatment of patients with non-cardioembolic ischemic stroke in the primary analysis of...